Skip to content

Vera Therapeutics VERA Short-Term Investments

Short-Term Investments at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.75B+14.9%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$130.59M
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$419.03M+133%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$585.84M+12.6%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$116.94M-37.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$196.28M-62.1%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's short-term investments?
Vera Therapeutics (VERA) reported short-term investments of $482.41M in Q1 2026.
How has Vera Therapeutics's short-term investments changed year-over-year?
Vera Therapeutics's short-term investments decreased by 9.8% year-over-year, from $534.74M to $482.41M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.